Total number of protein in "GO:1903039" GO term: 174
| Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADA | ADA | P00813 | Adenosine deaminase | chr20 | GO:1903039 | Not Cancer Driver | No | 50 | 0.138 | 44 | 9 | 0.205 | 27 |
| ADAM8 | ADAM8 | P78325 | Disintegrin and metalloproteinase domain-containing protein 8 | chr10 | GO:1903039 | Not Cancer Driver | No | 82 | 0.1 | 230 | 13 | 0.057 | 0 |
| AGER_ENST00000375076 | AGER | Q15109 | Advanced glycosylation end product-specific receptor | chr6 | GO:1903039 | Not Cancer Driver | No | 31 | 0.077 | 297 | 21 | 0.071 | 0 |
| AKT1_ENST00000349310 | AKT1 | P31749 | RAC-alpha serine/threonine-protein kinase | chr14 | GO:1903039 | Census, Compendium | Yes | 108 | 0.225 | 158 | 24 | 0.152 | 4 |
| ALOX5 | ALOX5 | P09917 | Polyunsaturated fatty acid 5-lipoxygenase | chr10 | GO:1903039 | Not Cancer Driver | No | 129 | 0.191 | 16 | 2 | 0.125 | 0 |
| AMBRA1_ENST00000458649 | AMBRA1 | Q9C0C7 | Activating molecule in BECN1-regulated autophagy protein 1 | chr11 | GO:1903039 | Not Cancer Driver | No | 173 | 0.133 | 788 | 103 | 0.131 | 0 |
| ANXA1_ENST00000257497 | ANXA1 | P04083 | Annexin A1 | chr9 | GO:1903039 | Not Cancer Driver | No | 59 | 0.171 | 61 | 12 | 0.197 | 0 |
| AP3B1 | AP3B1 | O00203 | AP-3 complex subunit beta-1 | chr5 | GO:1903039 | Not Cancer Driver | No | 126 | 0.115 | 316 | 31 | 0.098 | 1 |
| AP3D1_ENST00000345016 | AP3D1 | O14617 | AP-3 complex subunit delta-1 | chr19 | GO:1903039 | Not Cancer Driver | No | 138 | 0.12 | 404 | 59 | 0.146 | 0 |
| BCL6_ENST00000232014 | BCL6 | P41182 | B-cell lymphoma 6 protein | chr3 | GO:1903039 | Census, Compendium | Yes | 134 | 0.19 | 328 | 67 | 0.204 | 0 |
| BTN2A2 | BTN2A2 | Q8WVV5 | Butyrophilin subfamily 2 member A2 | chr6 | GO:1903039 | Not Cancer Driver | No | 92 | 0.176 | 24 | 2 | 0.083 | 0 |
| CARD11 | CARD11 | Q9BXL7 | Caspase recruitment domain-containing protein 11 | chr7 | GO:1903039 | Census, Compendium | Yes | 303 | 0.263 | 530 | 140 | 0.264 | 5 |
| CAV1 | CAV1 | Q03135 | Caveolin-1 | chr7 | GO:1903039 | Not Cancer Driver | No | 30 | 0.169 | 2 | 0 | 0.0 | 0 |
| CBFB_ENST00000290858 | CBFB | Q13951 | Core-binding factor subunit beta | chr16 | GO:1903039 | Census, Compendium | Yes | 39 | 0.214 | 94 | 17 | 0.181 | 0 |
| CCL19 | CCL19 | Q99731 | C-C motif chemokine 19 | chr9 | GO:1903039 | Not Cancer Driver | No | 10 | 0.102 | 7 | 0 | 0.0 | 0 |
| CCL21 | CCL21 | O00585 | C-C motif chemokine 21 | chr9 | GO:1903039 | Not Cancer Driver | No | 14 | 0.104 | 59 | 6 | 0.102 | 0 |
| CCR2_ENST00000400888 | CCR2 | P41597 | C-C chemokine receptor type 2 | chr3 | GO:1903039 | Not Cancer Driver | No | 81 | 0.217 | 23 | 1 | 0.043 | 0 |
| CCR7 | CCR7 | P32248 | C-C chemokine receptor type 7 | chr17 | GO:1903039 | Census, Compendium | Yes | 50 | 0.132 | 0 | 0 | 0.0 | 0 |
| CD160_ENST00000369288 | CD160 | O95971 | CD160 antigen | chr1 | GO:1903039 | Not Cancer Driver | No | 20 | 0.11 | 2 | 0 | 0.0 | 0 |
| CD274 | CD274 | Q9NZQ7 | Programmed cell death 1 ligand 1 | chr9 | GO:1903039 | Census | Yes | 29 | 0.1 | 54 | 9 | 0.167 | 0 |
| CD28 | CD28 | P10747 | T-cell-specific surface glycoprotein CD28 | chr2 | GO:1903039 | Census | Yes | 42 | 0.191 | 18 | 10 | 0.556 | 0 |
| CD3E | CD3E | P07766 | T-cell surface glycoprotein CD3 epsilon chain | chr11 | GO:1903039 | Not Cancer Driver | No | 28 | 0.135 | 72 | 12 | 0.167 | 0 |
| CD40LG | CD40LG | P29965 | CD40 ligand | chrX | GO:1903039 | Not Cancer Driver | No | 56 | 0.215 | 24 | 7 | 0.292 | 32 |
| CD44 | CD44 | P16070 | CD44 antigen | chr11 | GO:1903039 | Not Cancer Driver | No | 75 | 0.101 | 542 | 60 | 0.111 | 0 |
| CD46_ENST00000358170 | CD46 | P15529 | Membrane cofactor protein | chr1 | GO:1903039 | Not Cancer Driver | No | 53 | 0.135 | 52 | 4 | 0.077 | 5 |
| CD5 | CD5 | P06127 | T-cell surface glycoprotein CD5 | chr11 | GO:1903039 | Not Cancer Driver | No | 67 | 0.135 | 146 | 19 | 0.13 | 0 |
| CD55_ENST00000367064 | CD55 | P08174 | Complement decay-accelerating factor | chr1 | GO:1903039 | Not Cancer Driver | No | 45 | 0.118 | 128 | 13 | 0.102 | 1 |
| CD80_ENST00000478182 | CD80 | P33681 | T-lymphocyte activation antigen CD80 | chr3 | GO:1903039 | Not Cancer Driver | No | 50 | 0.174 | 26 | 5 | 0.192 | 0 |
| CD81 | CD81 | P60033 | CD81 antigen | chr11 | GO:1903039 | Not Cancer Driver | No | 28 | 0.119 | 0 | 0 | 0.0 | 0 |
| CD83 | CD83 | Q01151 | CD83 antigen | chr6 | GO:1903039 | Not Cancer Driver | No | 24 | 0.117 | 48 | 8 | 0.167 | 0 |
| CD86 | CD86 | P42081 | T-lymphocyte activation antigen CD86 | chr3 | GO:1903039 | Not Cancer Driver | No | 90 | 0.274 | 56 | 18 | 0.321 | 0 |
| CHST2 | CHST2 | Q9Y4C5 | Carbohydrate sulfotransferase 2 | chr3 | GO:1903039 | Not Cancer Driver | No | 98 | 0.185 | 136 | 11 | 0.081 | 0 |
| CHST4_ENST00000539698 | CHST4 | Q8NCG5 | Carbohydrate sulfotransferase 4 | chr16 | GO:1903039 | Not Cancer Driver | No | 59 | 0.153 | 7 | 0 | 0.0 | 0 |
| CR1_ENST00000367053 | CR1 | P17927 | Complement receptor type 1 | chr1 | GO:1903039 | Compendium | Yes | 383 | 0.188 | 151 | 42 | 0.278 | 0 |
| CSK_ENST00000439220 | CSK | P41240 | Tyrosine-protein kinase CSK | chr15 | GO:1903039 | Not Cancer Driver | No | 41 | 0.091 | 18 | 1 | 0.056 | 0 |
| DOCK8 | DOCK8 | Q8NF50 | Dedicator of cytokinesis protein 8 | chr9 | GO:1903039 | Not Cancer Driver | No | 321 | 0.153 | 312 | 60 | 0.192 | 1 |
| DPP4 | DPP4 | P27487 | Dipeptidyl peptidase 4 | chr2 | GO:1903039 | Not Cancer Driver | No | 151 | 0.197 | 8 | 1 | 0.125 | 0 |
| DUSP10 | DUSP10 | Q9Y6W6 | Dual specificity protein phosphatase 10 | chr1 | GO:1903039 | Not Cancer Driver | No | 81 | 0.168 | 135 | 24 | 0.178 | 0 |
| EBI3 | EBI3 | Q14213 | Interleukin-27 subunit beta | chr19 | GO:1903039 | Not Cancer Driver | No | 32 | 0.14 | 10 | 1 | 0.1 | 0 |
| EFNB1 | EFNB1 | P98172 | Ephrin-B1 | chrX | GO:1903039 | Not Cancer Driver | No | 46 | 0.133 | 126 | 14 | 0.111 | 19 |
| EFNB2_ENST00000245323 | EFNB2 | P52799 | Ephrin-B2 | chr13 | GO:1903039 | Not Cancer Driver | No | 42 | 0.126 | 97 | 15 | 0.155 | 0 |
| EFNB3 | EFNB3 | Q15768 | Ephrin-B3 | chr17 | GO:1903039 | Not Cancer Driver | No | 45 | 0.132 | 183 | 22 | 0.12 | 0 |
| EGR3 | EGR3 | Q06889 | Early growth response protein 3 | chr8 | GO:1903039 | Not Cancer Driver | No | 60 | 0.155 | 252 | 46 | 0.183 | 0 |
| ELANE_ENST00000263621 | ELANE | P08246 | Neutrophil elastase | chr19 | GO:1903039 | Not Cancer Driver | No | 39 | 0.146 | 18 | 3 | 0.167 | 89 |
| EPO | EPO | P01588 | Erythropoietin | chr7 | GO:1903039 | Not Cancer Driver | No | 27 | 0.14 | 9 | 1 | 0.111 | 1 |
| ETS1_ENST00000319397 | ETS1 | P14921 | Protein C-ets-1 | chr11 | GO:1903039 | Not Cancer Driver | No | 68 | 0.154 | 78 | 9 | 0.115 | 0 |
| FADD | FADD | Q13158 | FAS-associated death domain protein | chr11 | GO:1903039 | Not Cancer Driver | No | 26 | 0.125 | 45 | 10 | 0.222 | 1 |
| FAM49B_ENST00000519540 | CYRIB | Q9NUQ9 | CYFIP-related Rac1 interactor B | chr8 | GO:1903039 | Not Cancer Driver | No | 53 | 0.164 | 78 | 11 | 0.141 | 0 |
| FLOT2 | FLOT2 | Q14254 | Flotillin-2 | chr17 | GO:1903039 | Not Cancer Driver | No | 56 | 0.131 | 20 | 3 | 0.15 | 0 |
| FOXO3 | FOXO3 | O43524 | Forkhead box protein O3 | chr6 | GO:1903039 | Census, Compendium | Yes | 70 | 0.104 | 595 | 68 | 0.114 | 0 |
| FOXP3 | FOXP3 | Q9BZS1 | Forkhead box protein P3 | chrX | GO:1903039 | Not Cancer Driver | No | 38 | 0.088 | 186 | 16 | 0.086 | 10 |
| FUT4 | FUT4 | P22083 | Alpha-(1,3)-fucosyltransferase 4 | chr11 | GO:1903039 | Not Cancer Driver | No | 49 | 0.092 | 193 | 9 | 0.047 | 0 |
| FUT7 | FUT7 | Q11130 | Alpha-(1,3)-fucosyltransferase 7 | chr9 | GO:1903039 | Not Cancer Driver | No | 28 | 0.082 | 25 | 3 | 0.12 | 0 |
| FYN | FYN | P06241 | Tyrosine-protein kinase Fyn | chr6 | GO:1903039 | Not Cancer Driver | No | 92 | 0.171 | 70 | 13 | 0.186 | 0 |
| GLI2_ENST00000361492 | GLI2 | P10070 | Zinc finger protein GLI2 | chr2 | GO:1903039 | Not Cancer Driver | No | 287 | 0.181 | 1403 | 244 | 0.174 | 2 |
| GLI3 | GLI3 | P10071 | Transcriptional activator GLI3 | chr7 | GO:1903039 | Not Cancer Driver | No | 385 | 0.244 | 1352 | 327 | 0.242 | 7 |
| GPAM | GPAM | Q9HCL2 | Glycerol-3-phosphate acyltransferase 1, mitochondrial | chr10 | GO:1903039 | Not Cancer Driver | No | 108 | 0.13 | 83 | 7 | 0.084 | 0 |
| HAS2 | HAS2 | Q92819 | Hyaluronan synthase 2 | chr8 | GO:1903039 | Not Cancer Driver | No | 100 | 0.181 | 17 | 7 | 0.412 | 0 |
| HHLA2_ENST00000489514 | HHLA2 | Q9UM44 | HERV-H LTR-associating protein 2 | chr3 | GO:1903039 | Not Cancer Driver | No | 85 | 0.205 | 57 | 10 | 0.175 | 0 |
| HLA-A_ENST00000376809 | HLA-A | P04439 | HLA class I histocompatibility antigen, A alpha chain | chr6 | GO:1903039 | Census, Compendium | Yes | 128 | 0.351 | 125 | 60 | 0.48 | 0 |
| HLA-DMB | HLA-DMB | P28068 | HLA class II histocompatibility antigen, DM beta chain | chr6 | GO:1903039 | Not Cancer Driver | No | 41 | 0.156 | 41 | 9 | 0.22 | 0 |
| HLA-DRA | HLA-DRA | P01903 | HLA class II histocompatibility antigen, DR alpha chain | chr6 | GO:1903039 | Not Cancer Driver | No | 52 | 0.205 | 12 | 1 | 0.083 | 0 |
| HLA-DRB1 | HLA-DRB1 | P01911 | HLA class II histocompatibility antigen, DRB1 beta chain | chr6 | GO:1903039 | Not Cancer Driver | No | 48 | 0.18 | 12 | 1 | 0.083 | 0 |
| HLA-E | HLA-E | P13747 | HLA class I histocompatibility antigen, alpha chain E | chr6 | GO:1903039 | Not Cancer Driver | No | 63 | 0.176 | 138 | 39 | 0.283 | 0 |
| HLA-G_ENST00000360323 | HLA-G | P17693 | HLA class I histocompatibility antigen, alpha chain G | chr6 | GO:1903039 | Not Cancer Driver | No | 94 | 0.278 | 85 | 22 | 0.259 | 0 |
| HLX | HLX | Q14774 | H2.0-like homeobox protein | chr1 | GO:1903039 | Not Cancer Driver | No | 107 | 0.219 | 412 | 98 | 0.238 | 0 |
| HMGB1_ENST00000405805 | HMGB1 | P09429 | High mobility group protein B1 | chr13 | GO:1903039 | Not Cancer Driver | No | 25 | 0.116 | 203 | 20 | 0.099 | 0 |
| HSPH1_ENST00000320027 | HSPH1 | Q92598 | Heat shock protein 105 kDa | chr13 | GO:1903039 | Not Cancer Driver | No | 103 | 0.12 | 323 | 42 | 0.13 | 0 |
| ICOS | ICOS | Q9Y6W8 | Inducible T-cell costimulator | chr2 | GO:1903039 | Not Cancer Driver | No | 36 | 0.181 | 0 | 0 | 0.0 | 0 |
| ICOSLG_ENST00000407780 | ICOSLG | O75144 | ICOS ligand | chr21 | GO:1903039 | Not Cancer Driver | No | 25 | 0.083 | 30 | 2 | 0.067 | 0 |
| IFNG | IFNG | P01579 | Interferon gamma | chr12 | GO:1903039 | Not Cancer Driver | No | 51 | 0.307 | 23 | 6 | 0.261 | 0 |
| IGF1_ENST00000307046 | IGF1 | P05019 | Insulin-like growth factor I | chr12 | GO:1903039 | Not Cancer Driver | No | 45 | 0.231 | 87 | 23 | 0.264 | 0 |
| IGF2_ENST00000641326 | IGF2 | P01344 | Insulin-like growth factor II | chr11 | GO:1903039 | Not Cancer Driver | No | 39 | 0.217 | 44 | 12 | 0.273 | 0 |
| IGFBP2 | IGFBP2 | P18065 | Insulin-like growth factor-binding protein 2 | chr2 | GO:1903039 | Not Cancer Driver | No | 32 | 0.098 | 171 | 24 | 0.14 | 0 |
| IHH | IHH | Q14623 | Indian hedgehog protein | chr2 | GO:1903039 | Not Cancer Driver | No | 58 | 0.141 | 111 | 15 | 0.135 | 6 |
| IL12B | IL12B | P29460 | Interleukin-12 subunit beta | chr5 | GO:1903039 | Not Cancer Driver | No | 48 | 0.146 | 42 | 2 | 0.048 | 0 |
| IL12RB1_ENST00000593993 | IL12RB1 | P42701 | Interleukin-12 receptor subunit beta-1 | chr19 | GO:1903039 | Not Cancer Driver | No | 108 | 0.163 | 207 | 38 | 0.184 | 1 |
| IL18 | IL18 | Q14116 | Interleukin-18 | chr11 | GO:1903039 | Not Cancer Driver | No | 19 | 0.098 | 16 | 3 | 0.188 | 0 |
| IL1A | IL1A | P01583 | Interleukin-1 alpha | chr2 | GO:1903039 | Not Cancer Driver | No | 30 | 0.111 | 35 | 6 | 0.171 | 0 |
| IL1B | IL1B | P01584 | Interleukin-1 beta | chr2 | GO:1903039 | Not Cancer Driver | No | 39 | 0.145 | 16 | 3 | 0.188 | 0 |
| IL2 | IL2 | P60568 | Interleukin-2 | chr4 | GO:1903039 | Census | Yes | 24 | 0.157 | 6 | 1 | 0.167 | 0 |
| IL23A | IL23A | Q9NPF7 | Interleukin-23 subunit alpha | chr12 | GO:1903039 | Not Cancer Driver | No | 15 | 0.079 | 42 | 3 | 0.071 | 0 |
| IL23R | IL23R | Q5VWK5 | Interleukin-23 receptor | chr1 | GO:1903039 | Not Cancer Driver | No | 70 | 0.111 | 117 | 19 | 0.162 | 0 |
| IL27RA | IL27RA | Q6UWB1 | Interleukin-27 receptor subunit alpha | chr19 | GO:1903039 | Not Cancer Driver | No | 91 | 0.143 | 167 | 23 | 0.138 | 0 |
| IL2RA | IL2RA | P01589 | Interleukin-2 receptor subunit alpha | chr10 | GO:1903039 | Not Cancer Driver | No | 51 | 0.188 | 131 | 29 | 0.221 | 2 |
| IL4I1_ENST00000391826 | IL4I1 | Q96RQ9 | L-amino-acid oxidase | chr19 | GO:1903039 | Not Cancer Driver | No | 65 | 0.115 | 136 | 14 | 0.103 | 0 |
| IL4R_ENST00000543915 | IL4R | P24394 | Interleukin-4 receptor subunit alpha | chr16 | GO:1903039 | Not Cancer Driver | No | 133 | 0.161 | 420 | 64 | 0.152 | 0 |
| IL6 | IL6 | P05231 | Interleukin-6 | chr7 | GO:1903039 | Not Cancer Driver | No | 35 | 0.165 | 58 | 7 | 0.121 | 0 |
| IL7R | IL7R | P16871 | Interleukin-7 receptor subunit alpha | chr5 | GO:1903039 | Census, Compendium | Yes | 177 | 0.386 | 88 | 48 | 0.545 | 1 |
| IRAK1 | IRAK1 | P51617 | Interleukin-1 receptor-associated kinase 1 | chrX | GO:1903039 | Compendium | Yes | 71 | 0.1 | 337 | 39 | 0.116 | 0 |
| ITGA4 | ITGA4 | P13612 | Integrin alpha-4 | chr2 | GO:1903039 | Not Cancer Driver | No | 254 | 0.246 | 97 | 27 | 0.278 | 0 |
| ITGB2_ENST00000355153 | ITGB2 | P05107 | Integrin beta-2 | chr21 | GO:1903039 | Not Cancer Driver | No | 147 | 0.191 | 59 | 9 | 0.153 | 15 |
| ITPKB_ENST00000272117 | ITPKB | P27987 | Inositol-trisphosphate 3-kinase B | chr1 | GO:1903039 | Not Cancer Driver | No | 148 | 0.156 | 719 | 119 | 0.166 | 0 |
| JAK2 | JAK2 | O60674 | Tyrosine-protein kinase JAK2 | chr9 | GO:1903039 | Census, Compendium | Yes | 136 | 0.12 | 59 | 5 | 0.085 | 5 |
| JAK3 | JAK3 | P52333 | Tyrosine-protein kinase JAK3 | chr19 | GO:1903039 | Census, Compendium | Yes | 167 | 0.149 | 63 | 10 | 0.159 | 7 |
| KLRK1 | KLRK1 | P26718 | NKG2-D type II integral membrane protein | chr12 | GO:1903039 | Not Cancer Driver | No | 38 | 0.176 | 0 | 0 | 0.0 | 0 |
| LCK | LCK | P06239 | Tyrosine-protein kinase Lck | chr1 | GO:1903039 | Census | Yes | 86 | 0.169 | 94 | 13 | 0.138 | 1 |
| LEF1 | LEF1 | Q9UJU2 | Lymphoid enhancer-binding factor 1 | chr4 | GO:1903039 | Census | Yes | 64 | 0.16 | 370 | 57 | 0.154 | 0 |
| LGALS1 | LGALS1 | P09382 | Galectin-1 | chr22 | GO:1903039 | Not Cancer Driver | No | 16 | 0.119 | 0 | 0 | 0.0 | 0 |
| LGALS9 | LGALS9 | O00182 | Galectin-9 | chr17 | GO:1903039 | Not Cancer Driver | No | 54 | 0.152 | 65 | 16 | 0.246 | 0 |
| LILRB1_ENST00000396331 | LILRB1 | Q8NHL6 | Leukocyte immunoglobulin-like receptor subfamily B member 1 | chr19 | GO:1903039 | Not Cancer Driver | No | 203 | 0.312 | 291 | 97 | 0.333 | 0 |
| LILRB2_ENST00000314446 | LILRB2 | Q8N423 | Leukocyte immunoglobulin-like receptor subfamily B member 2 | chr19 | GO:1903039 | Not Cancer Driver | No | 148 | 0.248 | 235 | 50 | 0.213 | 0 |
| LILRB4 | LILRB4 | Q8NHJ6 | Leukocyte immunoglobulin-like receptor subfamily B member 4 | chr19 | GO:1903039 | Not Cancer Driver | No | 162 | 0.362 | 277 | 115 | 0.415 | 0 |
| LYN | LYN | P07948 | Tyrosine-protein kinase Lyn | chr8 | GO:1903039 | Census | Yes | 95 | 0.186 | 84 | 12 | 0.143 | 0 |
| MALT1 | MALT1 | Q9UDY8 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | chr18 | GO:1903039 | Census, Compendium | Yes | 75 | 0.091 | 139 | 12 | 0.086 | 1 |
| MAP3K8_ENST00000542547 | MAP3K8 | P41279 | Mitogen-activated protein kinase kinase kinase 8 | chr10 | GO:1903039 | Not Cancer Driver | No | 58 | 0.124 | 109 | 10 | 0.092 | 0 |
| MDK_ENST00000407067 | MDK | P21741 | Midkine | chr11 | GO:1903039 | Not Cancer Driver | No | 15 | 0.105 | 20 | 2 | 0.1 | 0 |
| MYB_ENST00000367814 | MYB | P10242 | Transcriptional activator Myb | chr6 | GO:1903039 | Census | Yes | 82 | 0.128 | 528 | 69 | 0.131 | 0 |
| NCKAP1L | NCKAP1L | P55160 | Nck-associated protein 1-like | chr12 | GO:1903039 | Not Cancer Driver | No | 247 | 0.219 | 51 | 10 | 0.196 | 4 |
| NFAT5_ENST00000354436 | NFAT5 | O94916 | Nuclear factor of activated T-cells 5 | chr16 | GO:1903039 | Not Cancer Driver | No | 142 | 0.093 | 1307 | 119 | 0.091 | 0 |
| NFKBID | NFKBID | Q8NI38 | NF-kappa-B inhibitor delta | chr19 | GO:1903039 | Not Cancer Driver | No | 47 | 0.15 | 124 | 20 | 0.161 | 0 |
| NFKBIZ | NFKBIZ | Q9BYH8 | NF-kappa-B inhibitor zeta | chr3 | GO:1903039 | Not Cancer Driver | No | 96 | 0.134 | 443 | 53 | 0.12 | 0 |
| NKAP | NKAP | Q8N5F7 | NF-kappa-B-activating protein | chrX | GO:1903039 | Not Cancer Driver | No | 80 | 0.193 | 409 | 77 | 0.188 | 3 |
| NLRP3_ENST00000391828 | NLRP3 | Q96P20 | NACHT, LRR and PYD domains-containing protein 3 | chr1 | GO:1903039 | Not Cancer Driver | No | 339 | 0.327 | 64 | 33 | 0.516 | 37 |
| NOD2 | NOD2 | Q9HC29 | Nucleotide-binding oligomerization domain-containing protein 2 | chr16 | GO:1903039 | Not Cancer Driver | No | 169 | 0.163 | 40 | 4 | 0.1 | 15 |
| NR4A3_ENST00000395097 | NR4A3 | Q92570 | Nuclear receptor subfamily 4 group A member 3 | chr9 | GO:1903039 | Census | Yes | 83 | 0.133 | 298 | 37 | 0.124 | 0 |
| PCK1 | PCK1 | P35558 | Phosphoenolpyruvate carboxykinase, cytosolic [GTP] | chr20 | GO:1903039 | Not Cancer Driver | No | 142 | 0.228 | 110 | 28 | 0.255 | 1 |
| PDCD1LG2 | PDCD1LG2 | Q9BQ51 | Programmed cell death 1 ligand 2 | chr9 | GO:1903039 | Census, Compendium | Yes | 33 | 0.121 | 41 | 13 | 0.317 | 0 |
| PIK3CA | PIK3CA | P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | chr3 | GO:1903039 | Census, Compendium | Yes | 1669 | 1.563 | 38 | 11 | 0.289 | 30 |
| PNP | PNP | P00491 | Purine nucleoside phosphorylase | chr14 | GO:1903039 | Not Cancer Driver | No | 38 | 0.131 | 29 | 2 | 0.069 | 5 |
| PRKCQ | PRKCQ | Q04759 | Protein kinase C theta type | chr10 | GO:1903039 | Not Cancer Driver | No | 147 | 0.208 | 28 | 9 | 0.321 | 0 |
| PRKCZ | PRKCZ | Q05513 | Protein kinase C zeta type | chr1 | GO:1903039 | Not Cancer Driver | No | 70 | 0.118 | 116 | 11 | 0.095 | 0 |
| PTAFR_ENST00000305392 | PTAFR | P25105 | Platelet-activating factor receptor | chr1 | GO:1903039 | Not Cancer Driver | No | 42 | 0.123 | 0 | 0 | 0.0 | 0 |
| PTPN11_ENST00000351677 | PTPN11 | Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | chr12 | GO:1903039 | Census, Compendium | Yes | 129 | 0.218 | 260 | 38 | 0.146 | 60 |
| PTPN22 | PTPN22 | Q9Y2R2 | Tyrosine-protein phosphatase non-receptor type 22 | chr1 | GO:1903039 | Not Cancer Driver | No | 141 | 0.175 | 364 | 62 | 0.17 | 4 |
| PTPN6_ENST00000318974 | PTPN6 | P29350 | Tyrosine-protein phosphatase non-receptor type 6 | chr12 | GO:1903039 | Census, Compendium | Yes | 73 | 0.123 | 192 | 25 | 0.13 | 0 |
| PTPRC | PTPRC | P08575 | Receptor-type tyrosine-protein phosphatase C | chr1 | GO:1903039 | Census, Compendium | Yes | 315 | 0.241 | 462 | 107 | 0.232 | 0 |
| PYCARD | PYCARD | Q9ULZ3 | Apoptosis-associated speck-like protein containing a CARD | chr16 | GO:1903039 | Not Cancer Driver | No | 16 | 0.082 | 39 | 4 | 0.103 | 0 |
| RARA | RARA | P10276 | Retinoic acid receptor alpha | chr17 | GO:1903039 | Census, Compendium | Yes | 70 | 0.152 | 167 | 14 | 0.084 | 0 |
| RASAL3 | RASAL3 | Q86YV0 | RAS protein activator like-3 | chr19 | GO:1903039 | Not Cancer Driver | No | 114 | 0.113 | 536 | 68 | 0.127 | 0 |
| RASGRP1 | RASGRP1 | O95267 | RAS guanyl-releasing protein 1 | chr15 | GO:1903039 | Not Cancer Driver | No | 96 | 0.12 | 191 | 12 | 0.063 | 1 |
| RELA | RELA | Q04206 | Transcription factor p65 | chr11 | GO:1903039 | Compendium | Yes | 75 | 0.136 | 400 | 48 | 0.12 | 0 |
| RHOA | RHOA | P61586 | Transforming protein RhoA | chr3 | GO:1903039 | Census, Compendium | Yes | 99 | 0.513 | 46 | 13 | 0.283 | 2 |
| RIPK2 | RIPK2 | O43353 | Receptor-interacting serine/threonine-protein kinase 2 | chr8 | GO:1903039 | Not Cancer Driver | No | 63 | 0.117 | 143 | 20 | 0.14 | 0 |
| RPS3_ENST00000527446 | RPS3 | P23396 | 40S ribosomal protein S3 | chr11 | GO:1903039 | Not Cancer Driver | No | 22 | 0.091 | 48 | 4 | 0.083 | 0 |
| RUNX1_ENST00000344691 | RUNX1 | Q01196 | Runt-related transcription factor 1 | chr21 | GO:1903039 | Census, Compendium | Yes | 81 | 0.179 | 360 | 58 | 0.161 | 2 |
| RUNX3_ENST00000308873 | RUNX3 | Q13761 | Runt-related transcription factor 3 | chr1 | GO:1903039 | Not Cancer Driver | No | 59 | 0.142 | 331 | 45 | 0.136 | 0 |
| SART1 | SART1 | O43290 | U4/U6.U5 tri-snRNP-associated protein 1 | chr11 | GO:1903039 | Not Cancer Driver | No | 71 | 0.089 | 685 | 63 | 0.092 | 0 |
| SASH3 | SASH3 | O75995 | SAM and SH3 domain-containing protein 3 | chrX | GO:1903039 | Not Cancer Driver | No | 59 | 0.155 | 327 | 49 | 0.15 | 0 |
| SELE | SELE | P16581 | E-selectin | chr1 | GO:1903039 | Not Cancer Driver | No | 137 | 0.225 | 12 | 0 | 0.0 | 0 |
| SELP | SELP | P16109 | P-selectin | chr1 | GO:1903039 | Not Cancer Driver | No | 226 | 0.272 | 14 | 2 | 0.143 | 0 |
| SHH | SHH | Q15465 | Sonic hedgehog protein | chr7 | GO:1903039 | Not Cancer Driver | No | 56 | 0.121 | 139 | 14 | 0.101 | 81 |
| SKAP1_ENST00000584924 | SKAP1 | Q86WV1 | Src kinase-associated phosphoprotein 1 | chr17 | GO:1903039 | Not Cancer Driver | No | 67 | 0.187 | 130 | 27 | 0.208 | 0 |
| SLAMF1_ENST00000302035 | SLAMF1 | Q13291 | Signaling lymphocytic activation molecule | chr1 | GO:1903039 | Not Cancer Driver | No | 82 | 0.245 | 64 | 10 | 0.156 | 0 |
| SOCS1 | SOCS1 | O15524 | Suppressor of cytokine signaling 1 | chr16 | GO:1903039 | Census, Compendium | Yes | 22 | 0.104 | 66 | 3 | 0.045 | 2 |
| SOCS5 | SOCS5 | O75159 | Suppressor of cytokine signaling 5 | chr2 | GO:1903039 | Not Cancer Driver | No | 84 | 0.157 | 297 | 46 | 0.155 | 0 |
| SOX12 | SOX12 | O15370 | Transcription factor SOX-12 | chr20 | GO:1903039 | Not Cancer Driver | No | 20 | 0.063 | 307 | 19 | 0.062 | 0 |
| SOX13 | SOX13 | Q9UN79 | Transcription factor SOX-13 | chr1 | GO:1903039 | Not Cancer Driver | No | 85 | 0.137 | 564 | 77 | 0.137 | 0 |
| SOX4 | SOX4 | Q06945 | Transcription factor SOX-4 | chr6 | GO:1903039 | Not Cancer Driver | No | 28 | 0.059 | 400 | 24 | 0.06 | 4 |
| SRC_ENST00000358208 | SRC | P12931 | Proto-oncogene tyrosine-protein kinase Src | chr20 | GO:1903039 | Census | Yes | 53 | 0.099 | 130 | 11 | 0.085 | 1 |
| ST3GAL4_ENST00000534083 | ST3GAL4 | Q11206 | CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 | chr11 | GO:1903039 | Not Cancer Driver | No | 31 | 0.093 | 3 | 2 | 0.667 | 0 |
| STAT5B | STAT5B | P51692 | Signal transducer and activator of transcription 5B | chr17 | GO:1903039 | Census, Compendium | Yes | 93 | 0.118 | 144 | 19 | 0.132 | 5 |
| SYK_ENST00000375746 | SYK | P43405 | Tyrosine-protein kinase SYK | chr9 | GO:1903039 | Census | Yes | 96 | 0.151 | 131 | 27 | 0.206 | 5 |
| TESPA1 | TESPA1 | A2RU30 | Protein TESPA1 | chr12 | GO:1903039 | Not Cancer Driver | No | 127 | 0.244 | 284 | 84 | 0.296 | 0 |
| TGFBR2_ENST00000295754 | TGFBR2 | P37173 | TGF-beta receptor type-2 | chr3 | GO:1903039 | Census, Compendium | Yes | 106 | 0.187 | 60 | 16 | 0.267 | 25 |
| TMIGD2 | TMIGD2 | Q96BF3 | Transmembrane and immunoglobulin domain-containing protein 2 | chr19 | GO:1903039 | Not Cancer Driver | No | 57 | 0.202 | 120 | 32 | 0.267 | 0 |
| TNF | TNF | P01375 | Tumor necrosis factor | chr6 | GO:1903039 | Not Cancer Driver | No | 24 | 0.103 | 45 | 3 | 0.067 | 0 |
| TNFRSF13C | TNFRSF13C | Q96RJ3 | Tumor necrosis factor receptor superfamily member 13C | chr22 | GO:1903039 | Not Cancer Driver | No | 17 | 0.092 | 128 | 15 | 0.117 | 0 |
| TNFRSF14 | TNFRSF14 | Q92956 | Tumor necrosis factor receptor superfamily member 14 | chr1 | GO:1903039 | Census, Compendium | Yes | 33 | 0.117 | 54 | 8 | 0.148 | 0 |
| TNFSF13B | TNFSF13B | Q9Y275 | Tumor necrosis factor ligand superfamily member 13B | chr13 | GO:1903039 | Not Cancer Driver | No | 41 | 0.144 | 91 | 15 | 0.165 | 0 |
| TNFSF14 | TNFSF14 | O43557 | Tumor necrosis factor ligand superfamily member 14 | chr19 | GO:1903039 | Not Cancer Driver | No | 58 | 0.242 | 18 | 1 | 0.056 | 0 |
| TNFSF4 | TNFSF4 | P23510 | Tumor necrosis factor ligand superfamily member 4 | chr1 | GO:1903039 | Not Cancer Driver | No | 28 | 0.153 | 1 | 0 | 0.0 | 0 |
| TNFSF9 | TNFSF9 | P41273 | Tumor necrosis factor ligand superfamily member 9 | chr19 | GO:1903039 | Not Cancer Driver | No | 32 | 0.126 | 39 | 4 | 0.103 | 0 |
| TRAF6_ENST00000348124 | TRAF6 | Q9Y4K3 | TNF receptor-associated factor 6 | chr11 | GO:1903039 | Not Cancer Driver | No | 67 | 0.128 | 62 | 7 | 0.113 | 0 |
| TYK2 | TYK2 | P29597 | Non-receptor tyrosine-protein kinase TYK2 | chr19 | GO:1903039 | Not Cancer Driver | No | 148 | 0.125 | 213 | 29 | 0.136 | 0 |
| VAV1 | VAV1 | P15498 | Proto-oncogene vav | chr19 | GO:1903039 | Census, Compendium | Yes | 165 | 0.195 | 113 | 19 | 0.168 | 0 |
| VNN1 | VNN1 | O95497 | Pantetheinase | chr6 | GO:1903039 | Not Cancer Driver | No | 88 | 0.172 | 20 | 5 | 0.25 | 0 |
| VSIR | VSIR | Q9H7M9 | V-type immunoglobulin domain-containing suppressor of T-cell activation | chr10 | GO:1903039 | Not Cancer Driver | No | 52 | 0.167 | 135 | 19 | 0.141 | 0 |
| XCL1 | XCL1 | P47992 | Lymphotactin | chr1 | GO:1903039 | Not Cancer Driver | No | 28 | 0.246 | 35 | 11 | 0.314 | 0 |
| YES1_ENST00000314574 | YES1 | P07947 | Tyrosine-protein kinase Yes | chr18 | GO:1903039 | Not Cancer Driver | No | 65 | 0.12 | 62 | 10 | 0.161 | 0 |
| ZAP70 | ZAP70 | P43403 | Tyrosine-protein kinase ZAP-70 | chr2 | GO:1903039 | Not Cancer Driver | No | 126 | 0.204 | 117 | 17 | 0.145 | 8 |
| ZBTB1 | ZBTB1 | Q9Y2K1 | Zinc finger and BTB domain-containing protein 1 | chr14 | GO:1903039 | Not Cancer Driver | No | 70 | 0.098 | 271 | 27 | 0.1 | 0 |
| ZBTB16_ENST00000392996 | ZBTB16 | Q05516 | Zinc finger and BTB domain-containing protein 16 | chr11 | GO:1903039 | Census, Compendium | Yes | 131 | 0.195 | 268 | 50 | 0.187 | 1 |
| ZBTB7B_ENST00000368426 | ZBTB7B | O15156 | Zinc finger and BTB domain-containing protein 7B | chr1 | GO:1903039 | Compendium | Yes | 103 | 0.191 | 353 | 70 | 0.198 | 0 |